Human Papilloma Virus Vaccination

Rosalik, Kendal Frances; Tarney, Christopher M.; Han, Jasmine

doi:10.3390/v13061091

Cited by 39 publications

(45 citation statements)

References 44 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Three human papillomavirus (HPV) vaccines have been licenced globally around the world – bivalent, quadrivalent and nonvalent vaccines. If administered before sexual debut, these vaccines offer protection against high-risk HPV types 16 and 18, which are responsible for approximately 70% of cases of cervical cancer, and other cancers affecting the vulva, vagina, penis, anus and oral cavity ( Rosalik et al, 2021 ).…”

Section: Introductionmentioning

confidence: 99%

Human papillomavirus vaccine communication materials for young people in English-speaking countries: A content analysis

Fisher

Chantler

Mounier-Jack

et al. 2022

Health Education Journal

View full text Add to dashboard Cite

Objective: To undertake a content analysis of human papillomavirus (HPV) vaccine communication materials available to young people. Design: Content analysis. Setting: Majority English-speaking countries. Methods: Between March and April 2020, a web engine was utilised to search for and retrieve relevant communication materials. Content analysis was used to describe how the following key issues were covered: (1) side effects, (2) safety, (3) practicalities related to receiving the HPV vaccine and (4) gender-specific information. Results: A total of 44 separate communication materials were retrieved, predominantly videos, webpages and leaflets. There was a focus on mild side effects of the vaccine (43.2%), with less frequent reference being made to moderate or serious side effects (22.7%). Reassurance concerning the safety profile of vaccine was communicated by referencing the widespread use of the HPV vaccine (31.8%). Information regarding formal criteria for entry into the vaccination programme emphasised country-specific eligibility criteria (59.1%), the setting in which vaccination was offered (38.6%) and the number of doses required (38.6%). Content intended to improve young people’s experiences of receiving the HPV vaccine was less often provided (22.7%). Gender-specific content usually related to specific HPV-related diseases (52.3%) and/or the availability of cervical cancer screening programmes (52.3%). Conclusion: A variety of different communication tools were retrieved encompassing a wide variety of formats and content, reflective of different vaccination programmes and the varied priorities of organisations producing the materials. Findings will inform the co-production of a tailored educational package to improve access to information by populations of young people identified as having lower HPV vaccine uptake.

show abstract

Section: Introductionmentioning

confidence: 99%

Human papillomavirus vaccine communication materials for young people in English-speaking countries: A content analysis

Fisher

Chantler

Mounier-Jack

et al. 2022

Health Education Journal

View full text Add to dashboard Cite

show abstract

“…Cervical cancer is the one of the main female reproductive system malignancies, which disturbs the health of women around the world. Although, with the development of screening strategy [ 16 ] and the popularization of HPV vaccine [ 17 ], the morbidity and mortality decreased in developed countries [ 18 ]. However, cervical carcinomas still result in numerous deaths in developing countries.…”

Section: Discussionmentioning

confidence: 99%

Vaginal Microbial Environment Skews Macrophage Polarization and Contributes to Cervical Cancer Development

Zhou

et al. 2022

Journal of Immunology Research

View full text Add to dashboard Cite

As a common female reproductive system malignancy, cervical cancer (CC) disturbs numerous women’s health. This study demonstrates the role of the vaginal microbial environment (Peptostreptococcus anaerobius) in cervical cancer. Functional assays, including cell proliferation assay, tube formation assay, and immunofluorescence staining, revealed the effect of Peptostreptococcus anaerobius-treated macrophages on cell proliferation and the angiogenesis process. The tube formation assay disclosed the function of Peptostreptococcus anaerobius-treated macrophages on angiogenesis. In vivo assays were also established to explore the impact of Peptostreptococcus anaerobius-treated macrophages on tumor migration. The results revealed that Peptostreptococcus anaerobius-induced macrophages boosted cervical cancer migration and angiogenesis both in vitro and in vivo. Then, this study unveiled that Peptostreptococcus anaerobius-induced macrophage secreted VEGF to stimulate the angiogenesis in cervical cancer. As a whole, Peptostreptococcus anaerobius-induced macrophage facilitates cervical cancer development through modulation of VEGF expression.

show abstract

“…The dissemination of the vaccine to underdeveloped nations has been uneven, even though vaccination with Cervarix and now, Gardasil, has demonstrated its effectiveness in the immunoprevention of cervical cancer. Vaccine uptake has encountered several difficulties, even in nations where the vaccine is widely available [ 16 ].…”

Section: Reviewmentioning

confidence: 99%

A Review on the Use of the HPV Vaccine in the Prevention of Cervical Cancer

Pathak¹,

Pajai²,

Kesharwani³

2022

Cureus

View full text Add to dashboard Cite

The main risk factor for invasive cervical carcinoma is persistent infection by the high-risk human papillomavirus (HPV). HPV is the most prevalent sexually transmitted infection (STI) and has been linked to 15 different cancers. Cervical cancer is one of the most frequent cancers among women, particularly in resource-limited countries. Cervical cancer is an HPV disease with the highest worldwide burden in resource-limited nations. With improved medical care and nationwide screening programmes, the mortality rate from cervical cancer has decreased in the past 40 years. Many developing nations have been shown to have inadequate knowledge and health-seeking practices, making proper awareness and immunisation programmes necessary. The best strategy to reduce the incidence of cervical cancer is through the administration of HPV vaccines along with routine cervical screening. The HPV vaccine is crucial for public health. Vaccinations against all HPV subtypes, namely, bivalent, quadrivalent, and nonavalent, are available. Financial issues are the main barrier to HPV vaccination. The framework for behavioural and social drivers of vaccination, which includes practical concerns, motivation, social processes, thoughts, and feelings, is widely used to uncover important aspects linked with HPV vaccination. The burden of cervical cancer due to HPV and the advantages of HPV vaccination are summarised in this review article.

show abstract

Human Papilloma Virus Vaccination

Cited by 39 publications

References 44 publications

Human papillomavirus vaccine communication materials for young people in English-speaking countries: A content analysis

Human papillomavirus vaccine communication materials for young people in English-speaking countries: A content analysis

Vaginal Microbial Environment Skews Macrophage Polarization and Contributes to Cervical Cancer Development

A Review on the Use of the HPV Vaccine in the Prevention of Cervical Cancer

Contact Info

Product

Resources

About